Sf9 Purification
Sf9 Purification - Related Videos
06:11
Production and Purification of Baculovirus for Gene Therapy Application
0 Views •
Cited by 13 •
2018
In this protocol, baculovirus is produced by transient transfection of baculovirus plasmid into Sf9 cells and amplified in a serum-free suspension culture. The supernatant is purified by heparin affinity chromatography and further concentrated by ultracentrifugation. This protocol is useful for the production and purification of baculovirus for gene therapy application.
06:17
Expression and Purification of Virus-like Particles for Vaccination
0 Views •
Cited by 28 •
2016
Here, we present a protocol for synthesizing virus-like particles using either baculovirus or mammalian expression systems, and ultracentrifugation purification. This highly customizable approach is used to identify viral antigens as vaccine targets in a safe and flexible manner.
08:16
Plasmid Purification
0 Views •
2023
Plasmid purification is a technique used to isolate and purify plasmid DNA from genomic DNA, proteins, ribosomes, and the bacterial cell wall. A plasmid is a small, circular, double-stranded DNA that is used as a carrier of specific DNA molecules. When introduced into a host organism via transformation, a plasmid will be replicated, creating numerous copies of the DNA fragment under study. In this video, a step-by-step generalized procedure is described for how to perform plasmid purification.
06:30
Gel Purification
0 Views •
2023
Gel purification is used to recover DNA fragments after electrophoretic separation. DNA recovery from an agarose gel includes three basic steps: binding, washing and eluting from a silica column. DNA is believed to bind to silica in the presence of high salt via a salt bridge. Following binding, DNA is washed of impurities and eluted under low salt conditions disrupting this interaction. This video goes through a step-by-step, generalized procedure for cutting out a band from the gel, gel...
11:22
GST-His purification: A Two-step Affinity Purification Protocol Yielding Full-length Purified Proteins
0 Views •
Cited by 18 •
2013
In the present protocol, we demonstrate a highly efficient and cost-effective small-scale protein purification method, which allows purification of recombinant proteins by uniquely combining a cleavable GST-tag and a small His-tag.
FAQs
Each chromatographic method removes a different class of material. Affinity chromatography separates proteins through selective binding, ion-exchange chromatography distinguishes molecules by charge, and size-exclusion chromatography separates them by molecular size. Using these methods sequentially increases purity and can also concentrate the recombinant protein, producing a preparation better suited to biochemical assays and structural investigations.
Lysis must release recombinant protein from Sf9 cells while limiting conditions that reduce protein activity. Buffer composition is therefore an important optimization variable because it influences protein preservation during cell disruption and subsequent separation. Appropriate choices help maintain a functional product, which is essential when the purified material will undergo enzymatic testing or other biochemical characterization.
These methods rely on distinct separation principles rather than providing interchangeable purification steps. Affinity methods use binding differences, ion-exchange methods use charge differences, and size-exclusion methods use molecular-size differences. Their complementary selectivity allows a workflow to remove contaminants that may remain after one separation principle, improving the cleanliness and suitability of the final protein preparation.
Following baculovirus-mediated expression, the Sf9 cells are disrupted by lysis to release their contents. Centrifugation or filtration then removes insoluble material, and the clarified sample undergoes chromatographic separation. Affinity, ion-exchange, or size-exclusion steps may be arranged sequentially, with buffer composition and operating conditions optimized to preserve activity while reducing host-cell and expression-system contaminants.
The workflow produces cleaner and more concentrated recombinant protein than the disrupted-cell mixture. That preparation can support enzymatic assays, protein-structure studies, antibody production, and broader biochemical characterization. Its value lies not only in removing unwanted material but also in preserving enough protein activity and quality for experiments that depend on a reliable purified sample.
Researchers should assess whether the process has enriched the recombinant protein, removed insoluble material, reduced contaminants, and retained useful activity. These outcomes determine whether the preparation is appropriate for downstream work such as structural analysis, enzymatic assays, antibody production, or functional characterization. Comparing results after successive purification stages helps guide optimization of the overall workflow.